Interestingly, synergistic reactivation of p16 has been demonstrated using decitabine and an HDACi, such as trischostatin A (TSA), in other cancers, including head and neck squamous cell carcinoma (HNSCC) [3, 6]. Here, CDKN2A is linked to cancer.